US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2224 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores
ME1003, Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
BN00011, Multiple organ normal tissue array, 48 cases/48 cores

Newly added tissue microarrays in recent month:

2015-03-23 ES353, Esophagus squamous cell carcinoma (grade III) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores
2015-03-23 KD701, Kidney cancer (grade I) tissue array with matched adjacent normal kidney tissue, 35 cases/70 cores
2015-03-23 PA242b, Pancreas cancer tissue array with adjacent normal pancreas tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PA242a
2015-03-23 PA805b, Pancreas cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores,replacing PA805a
2015-03-17 OV802a, Ovarian cancer tissue with normal tissue array, including TNM, pathology grade and clinical stage, 78 cases/80 cores, replacing OV802
2015-03-16 ES352, Esophagus squamous cell carcinoma (grade II) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores
2015-03-16 FCY450a, Frozen cynomolgus monkey multiple organ normal tissue array, 45 cases/45 cores, replacing FCY450
2015-03-16 CO802c, Colon cancer tissue array with adjacent colon tissue, including TNM, pathology grade and clinical stage and IHC markers (β-Catenin) results, 80 cases/80 cores, replacing CO802b
2015-03-16 FDA903, Frozen multiple organ normal tissue array, 45 cases/45 cores, replacing FDA902
2015-03-16 MS1001, Malignant mesothelioma tissue array, including TNM and clinical stage results, 50 cases/ 100 cores
2015-03-09 HN803c, Head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing HN803b
2015-03-09 BL802a, Bladder cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BL802
2015-03-09 LC818, Small cell lung cancer tissue array, including TNM and clinical stage and IHC markers (Syn) results, 80 cases/80 cores
2015-02-28 ES351, Esophagus squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores
2015-02-17 FDA9010, Multiple organ normal tissue array, 90 cases/90 cores
2015-02-17 BCN601, Multiple organ cancer with normal tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores
2015-02-17 LC814a, Lung cancer tissue array with matched metastatic lymph node, 40 cases/80 cores, replacing LC814
2015-02-17 BS17017a, Brain astrocytoma, glioblastomand adjacent normal brain tissue array, including pathology grade and IHC markers (GFAP) results, 63 cases/63 cores, replacing BS17017
2015-02-17 BC04022a, Lung cancer with matched adjacent and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 3 cores/case, replacing BC04022
2015-02-09 BC07015a, Kidney cancer tissue array with adjacent kidney tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC07015